Request Discount

Syphilis Immunoassay Diagnostics Market (Product Type - Analyzers, and Kits and Reagents; Technology - ELISA, CLIA, and Other Technologies; End User - Hospitals, Diagnostic Labs, and Blood Bank): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : January, 2020

  • Rep Id : HC0778

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Syphilis Immunoassay Diagnostics Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Syphilis Immunoassay Diagnostics Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Syphilis Immunoassay Diagnostics Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on the syphilis immunoassay diagnostics market provides an in-depth analysis of segments and sub-segments in the global as well as regional syphilis immunoassay diagnostics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional syphilis immunoassay diagnostics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global syphilis immunoassay diagnostics market. According to the report, the global syphilis immunoassay diagnostics market is projected to grow at a CAGR of 2.5% over the forecast period of 2019-2025.


Market Insight

Syphilis is a chronic bacterial disease that is mostly spread through sexual activity. It can be treated with antibiotics, especially in the early stage. According to the Centers for Disease Control and Prevention (CDC), in 2018, a total of 35,063 cases of primary and secondary syphilis were reported in the United States. Thereby, the number of cases in heterosexual men and women is also increasing. In Jan 2019, NuGenerex Diagnostics has announced that Express II Syphilis TreponemalAssay received the CE mark. The goal of the company is to provide a response in 30 minutes with a 90 % accurate result. This will helps to drive this market.


The growing rate of anonymous sex, sex under the influence of several drugs and the increasing number of unprotected sex both anal and oral are the major factor contributes to the growth of the syphilis immunoassay diagnostics market. Likewise, it is also gaining prominence in pregnant women which results in congenital abnormalities such as stillbirth, abortions and other abnormalities in pregnancy. This, in turn, propelling the market. Rising incidences of fatal syphilis diseases and disease-related high-economic burdens are anticipated to experience rapid growth for the same market. Implementation of the provider-initiated counseling and testing (PICT), as well as client-initiated counseling and testing (CICT) program is the factor enhancing the market. However, the lack of skilled professionals and the stigma associated with voluntary testing are the major factors hindering this market. Moreover, advancements in analyzer technologies such as PCR offers favorable opportunities in this market.


Geographically, Asia Pacific is the region that accounts for the highest share of the syphilis immunoassay diagnostics market. Increasing initiatives by the government and private associations are the major contributions to the growth of the market. In addition, the growing demand for the technologically advanced screening tests yet remains another factor impelling the market. Thailand is the first country that has eliminated mother-to-child transmission of syphilis and reduced transmission rates to less than 2%. Mostly syphilis is found in developing countries with similar trends now observed in developed nations as well. For instance, North America is expected to grow at the highest CAGR in the forecast period.

Global Syphilis Immunoassay Diagnostics Market


Segment Covered

The report on the global syphilis immunoassay diagnostics market covers segments such as product type, technology, and end user. On the basis of product type, the sub-markets include analyzers, and kits and reagents. On the basis of technology, the sub-markets include ELISA, CLIA, and other technologies. On the basis of end user, the sub-markets include hospitals, diagnostic labs, and blood bank.


Companies Profiled:

The report provides profiles of the companies in the market such as Danaher, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, DiaSorin S.p.A., Abbott Laboratories, Ortho Clinical Diagnostics, Shenzhen New Industries Biomedical Engineering Co., Ltd., Gold Standard Diagnostics, NuGenerex Diagnostics, bioMérieux SA, and Fujirebio, Inc.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of syphilis immunoassay diagnostics market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount